{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GIFLF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GIFLF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GIFLF\",,,,,undefined,":{"symbol":"GIFLF","market":"US","secType":"STK","nameCN":"Grifols Sa","latestPrice":10.95,"timestamp":1748894400000,"preClose":10.453325,"halted":0,"volume":3000,"delay":15,"floatShares":547935885,"shares":679629199,"eps":0.309265,"marketStatus":"Pre-Mkt","change":0.496675,"latestTime":"06-02 16:00:00 EDT Delay","open":10.95,"high":10.95,"low":10.95,"amount":32850,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.309265,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1748957400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":10.95,"volumeRatio":8.219181910303904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GIFLF\",,,,,undefined,":{"symbol":"GIFLF","floatShares":547935885,"roa":"3.99%","roe":"3.45%","lyrEps":0.239028,"volumeRatio":8.219181910303904,"shares":679629199,"dividePrice":0.001,"high":10.95,"amplitude":0,"preClose":10.453325,"low":10.95,"week52Low":8.4,"pbRate":"1.16","psRate":"0.88","week52High":11.39,"institutionHeld":0,"latestPrice":10.95,"eps":0.309265,"divideRate":0.000091,"volume":3000,"delay":15,"ttmEps":0.309265,"open":10.95,"prevYearClose":9.55,"prevWeekClose":10.4533,"prevMonthClose":10.4533,"prevQuarterClose":11.3,"fiveDayClose":10.4533,"twentyDayClose":8.5,"sixtyDayClose":11.3},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GIFLF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GIFLF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514877330","title":"Grifols SA (GIFLF) (Q4 2024) Earnings Call Highlights: Record Revenues and Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2514877330","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514877330?lang=en_us&edition=fundamental","pubTime":"2025-02-27 19:00","pubTimestamp":1740654031,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Grifols SA  achieved record revenues and adjusted EBITDA in 2024, with a 13.6% increase in Q4 revenues on a constant currency basis.The company significantly improved its balance sheet by reducing its leverage ratio from 6.8 times to 4.6 times within the year.The biopharma business, particularly the immunoglobulin franchise, showed robust growth, with IVIG sales growing by 15.6% in Q4.The company made substantial progress in its innovation pipeline, including advancements in fibrinogen and receiving a grant for Parkinson's research.The diagnostic segment saw a decline of 2% on a constant currency basis in Q4, indicating challenges in this area.Gross margins were affected by changes in accounting for US fee-for-services and GPO fees, impacting revenue growth profiles.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grifols-sa-giflf-q4-2024-110031332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GRFS","GIFLF"],"gpt_icon":0},{"id":"2482399463","title":"Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2482399463","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482399463?lang=en_us&edition=fundamental","pubTime":"2024-11-09 07:01","pubTimestamp":1731106916,"startTime":"0","endTime":"0","summary":"Revenue: Nearly EUR 1.8 billion in Q3, a 12.4% increase on a constant currency basis; year-to-date revenue reached EUR 5.2 billion, a 9.1% increase.Adjusted EBITDA: EUR 462 million for Q3 with a margin of nearly 26%, a 26.7% improvement at constant currency from the previous year.Free Cash Flow: Improved to EUR 127 million in Q3.Leverage Ratio: Reduced to 5.1 from 6.8 in Q1.BioPharma Growth: 12.1% increase in Q3 and 9.1% year-to-date on a constant currency basis.IG Franchise Growth: 16.6% increase in Q3 and 14.3% year-to-date on a constant currency basis.Subcutaneous IG Growth: 52% increase year-to-date on a constant currency basis.Albumin Growth: 11.7% increase in Q3 and 10.3% year-to-date on a constant currency basis.Diagnostics Growth: 1.3% increase in Q3 on a constant currency basis, 1.7% year-to-date.CapEx: Expected to be around EUR 280 million for 2024, primarily related to ImmunoTek.Liquidity: Stood at EUR 704 million at the end of Q3.GuruFocus has detected 7 Warning Signs with ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/EdOucecn69O2cEC3vtQgrw--~B/aD01MTt3PTIzMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/82faa6c98d62190215053bd23600bdcf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/EdOucecn69O2cEC3vtQgrw--~B/aD01MTt3PTIzMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/82faa6c98d62190215053bd23600bdcf"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grifols-sa-giflf-q3-2024-230156045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GIFLF","GRFS"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GIFLF\",params:#limit:5,,,undefined,":[{"date":"2024-05-14","symbol":"GIFLF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715673600000,"name":null,"time":"","dateTimestamp":1715659200000,"actualEps":null},{"market":"US","date":"2021-06-03","symbol":"GIFLF","amount":0.295122,"defaultRemindTime":1622727000000,"name":"Grifols Sa","recordDate":"2021-06-07","payableDate":"2021-06-04","currency":"EUR","type":"dividend","dateTimestamp":1622692800000},{"market":"US","date":"2020-10-26","symbol":"GIFLF","amount":0.1308889,"name":"Grifols Sa","recordDate":"2020-10-28","payableDate":"2020-10-27","currency":"EUR","type":"dividend","dateTimestamp":1603684800000},{"market":"US","date":"2019-12-02","symbol":"GIFLF","amount":0.162,"name":"Grifols Sa","recordDate":"2019-12-04","payableDate":"2019-12-03","currency":"EUR","type":"dividend","dateTimestamp":1575262800000},{"market":"US","date":"2019-06-07","symbol":"GIFLF","amount":0.1175656,"name":"Grifols Sa","recordDate":"2019-06-11","payableDate":"2019-06-10","currency":"EUR","type":"dividend","dateTimestamp":1559880000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GIFLF\",market:\"US\",,,undefined,":[{"executeDate":"2018-11-30","recordDate":"2018-12-03","paymentDate":"2018-12-04","value":0.162,"currency":"EUR"},{"executeDate":"2019-06-07","recordDate":"2019-06-10","paymentDate":"2019-06-11","value":0.1175656,"currency":"EUR"},{"executeDate":"2019-12-02","recordDate":"2019-12-03","paymentDate":"2019-12-04","value":0.162,"currency":"EUR"},{"executeDate":"2020-10-26","recordDate":"2020-10-27","paymentDate":"2020-10-28","value":0.1308889,"currency":"EUR"},{"executeDate":"2021-06-03","recordDate":"2021-06-04","paymentDate":"2021-06-07","value":0.295122,"currency":"EUR"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GIFLF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1333,"buy":0.4667,"hold":0.2667,"sell":0.1333,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4667,"analysts":15,"updateTime":1739592000000}}}